Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · Real-Time Price · USD
7.85
-0.37 (-4.50%)
At close: Jan 21, 2026, 4:00 PM EST
7.79
-0.06 (-0.76%)
After-hours: Jan 21, 2026, 7:28 PM EST
Ekso Bionics Holdings Employees
As of December 31, 2024, Ekso Bionics Holdings had 66 total employees, including 61 full-time and 5 part-time employees. The number of employees decreased by 6 or -8.33% compared to the previous year.
Employees
66
Change (1Y)
-6
Growth (1Y)
-8.33%
Revenue / Employee
$223,470
Profits / Employee
-$161,515
Market Cap
26.63M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 66 | -6 | -8.33% | 61 | 5 |
| Dec 31, 2023 | 72 | -1 | -1.37% | 70 | 2 |
| Dec 31, 2022 | 73 | 17 | 30.36% | 72 | 1 |
| Dec 31, 2021 | 56 | 16 | 40.00% | 55 | 1 |
| Dec 31, 2020 | 40 | -28 | -41.18% | 39 | 1 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Harvard Bioscience | 355 |
| Jin Medical International | 269 |
| Retractable Technologies | 227 |
| Bionano Genomics | 100 |
| Precision Optics Corporation | 90 |
| Femasys | 71 |
| Sharps Technology | 55 |
| Nephros | 31 |
EKSO News
- 17 hours ago - Ekso Bionics Prices $5.852 million Private Placement - GlobeNewsWire
- 23 days ago - Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale - GlobeNewsWire
- 6 weeks ago - Ekso Bionics Inks Agreement to Become the Exclusive U.S. Distributor of MediTouch's Groundbreaking BalanceTutor™ Rehabilitation System - GlobeNewsWire
- 3 months ago - Ekso Bionics Announces $3.7 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules - GlobeNewsWire
- 3 months ago - Ekso Bionics Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 6 months ago - Ekso Bionics Holdings, Inc. (EKSO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Ekso Bionics Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 6 months ago - Ekso Bionics to Report Second Quarter 2025 Financial Results on July 28 – Conference Call to Follow - GlobeNewsWire